A gentle touch: can tailored care rewire the brains of tiny preterm babies?

NCT ID NCT00914108

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study tests whether a family-centered developmental care program, called NIDCAP, can improve brain and behavior outcomes in preterm infants born with severe intrauterine growth restriction. The intervention involves weekly observations of each infant's behavior, with personalized suggestions for parents and staff on how to support the baby's development. Researchers will assess the infants' neurobehavioral and brain activity (via EEG) to see if this individualized care makes a difference. The goal is to understand if focusing on the infant's cues can positively influence their long-term development.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Newborn Individualized Developmental Care (NIDCAP), a behavioral intervention involving weekly neurobehavioral observations and tailored guidance for parents and staff
What this could lead to
If effective, this approach could improve long-term neurodevelopmental outcomes for preterm infants born with severe growth restriction, offering a low-risk, non-drug way to support their development.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply broadly. The intervention is behavioral and depends on consistent implementation, and benefits may be modest or hard to measure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAUTERINE GROWTH RETARDATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Children's Hospital Boston

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.